Adapting Pharmaceutical Companies’ Distribution and Supply Networks
Jaggaer
JUNE 23, 2020
From 2005 to 2015, most companies expanded their portfolio with at least 25% of total revenue coming from Asia Pacific and emerging markets. In the US, the Drug Supply Chain Security Act (DSCSA) was updated in 2017 to require compliance with FDA labeling guidelines. Other factors, like serialization, should also be considered.
Let's personalize your content